Venter Institute, SGI Researchers Build Bacterial Genome Editing Platform With Yeast, CRISPR/Cas9 | GenomeWeb

NEW YORK (GenomeWeb) – Scientists from Synthetic Genomics and the J. Craig Venter Institute have created a yeast-based platform for editing bacterial genomes using CRISPR/Cas9.

In a study published today in Scientific Reports, a team led by Venter and Daniel Gibson described how they engineered the small ribosomal subunit (16s) RNA of Mycoplasma mycoides, an essential gene for cell viability.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.